» Articles » PMID: 35223338

Patterns of Cannabis and Alcohol Co-Use: Substitution Versus Complementary Effects

Overview
Journal Alcohol Res
Specialty Psychiatry
Date 2022 Feb 28
PMID 35223338
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this review is to discuss the literature regarding the concurrent use (co-use) of alcohol and cannabis and competing hypotheses as to whether cannabis acts as a substitute for (i.e., replacing the effects of alcohol, resulting in decreased use) or a complement to (i.e., used to enhance the effects of alcohol, resulting in increased use) alcohol. The impact of cannabis use on alcohol-related outcomes has received increased attention in the wake of ongoing legalization of cannabis for both medical and recreational purposes. Evidence for both hypotheses exists in the literature across a broad range of data collection methods and samples and is carefully reviewed here. In addition, various mechanisms by which cannabis may act as an alcohol substitute or complement are explored in depth with the goal of better understanding equivocal findings.

Search Methods: This review includes articles that were identified from a search for studies on alcohol and cannabis co-use, with a specific focus on studies exploring complementary versus substitution aspects of co-use. Search terms were included in Google Scholar, PsycINFO, MEDLINE, and Web of Science. Eligible studies were those that measured alcohol and cannabis co-use in human samples in laboratory, survey, or ecological momentary assessment studies, or that directly referenced substitution or complementary patterns of use.

Search Results: Search results returned 650 articles, with 95 meeting inclusion criteria.

Discussion And Conclusions: Results of this review reveal compelling evidence for both substitution and complementary effects, suggesting nuanced yet significant distinctions across different populations examined in these studies. Several mechanisms for the impact of cannabis use on alcohol-related outcomes are identified, including patterns and context of co-use, timing and order of use, cannabinoid formulation, pharmacokinetic interactions, and user characteristics (including diagnostic status), all of which may influence substitution versus complementary effects. This review will inform future research studies examining this topic in both clinical and community samples and aid in the development of treatment and prevention efforts targeting those populations most vulnerable to negative consequences of co-use. Finally, this review highlights the need for additional research in more diverse samples and the use of mixed-methods designs to examine both pharmacological and contextual influences on co-use.

Citing Articles

Patterns of Cannabis Use among Women With HIV in the United States.

Haley D, Bullington B, Tien P, Knittel A, Bobitt J, Kempf M AIDS Behav. 2025; .

PMID: 40050488 DOI: 10.1007/s10461-025-04669-z.


The association between cannabis and alcohol co-use and momentary subjective effects: Risks for increasingly hazardous cannabis use.

Bedillion M, Ansell E Drug Alcohol Depend. 2025; 269:112595.

PMID: 39970575 PMC: 11890099. DOI: 10.1016/j.drugalcdep.2025.112595.


The Impact of Recreational Cannabis Markets on Cannabis Use Among Adolescents and Adults: A Synthetic Control Analysis.

Marinello S Cannabis. 2025; 8(1):50-64.

PMID: 39968487 PMC: 11831904. DOI: 10.26828/cannabis/2024/000224.


Patterns of cannabidiol use among marijuana users in the United States.

Park J Prev Med Rep. 2025; 50:102985.

PMID: 39911836 PMC: 11795096. DOI: 10.1016/j.pmedr.2025.102985.


Changes in population-level alcohol sales after non-medical cannabis legalisation in Canada.

Armstrong M, MacDonald-Spracklin R, Xiao J, Talarico R, Myran D Drug Alcohol Rev. 2025; 44(3):811-819.

PMID: 39901321 PMC: 11886499. DOI: 10.1111/dar.14010.


References
1.
Hughes J, Fingar J, Budney A, Naud S, Helzer J, Callas P . Marijuana use and intoxication among daily users: an intensive longitudinal study. Addict Behav. 2014; 39(10):1464-70. PMC: 4101026. DOI: 10.1016/j.addbeh.2014.05.024. View

2.
Hartman R, Brown T, Milavetz G, Spurgin A, Gorelick D, Gaffney G . Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clin Chem. 2015; 61(6):850-69. DOI: 10.1373/clinchem.2015.238287. View

3.
Karoly H, Mueller R, Bidwell L, Hutchison K . Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders. Alcohol Clin Exp Res. 2019; 44(2):340-353. DOI: 10.1111/acer.14256. View

4.
Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Hasko G . Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep. 2017; 7(1):12064. PMC: 5608708. DOI: 10.1038/s41598-017-10924-8. View

5.
Maccioni P, Bratzu J, Carai M, Colombo G, Gessa G . Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats. Cannabis Cannabinoid Res. 2021; 7(2):161-169. PMC: 9070735. DOI: 10.1089/can.2020.0132. View